SJ733: Clinical Trials

2 trials of SJ733, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1

Follow SJ733: new trials by email Literature Review of SJ733 trials Research Report on SJ733

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria
SJ733/TQ placebo, CQ/TQ Placebo, CQ/TQ - Malaria, Malaria Vivax
Phase 2Not yet recruitingR. Kiplin Guy1042026-12-012026-10-21
Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria
(+)-SJ000557733 (SJ733) - Malaria, Falciparum, Malaria, Vivax
Phase 2CompletedR. Kiplin Guy222021-04-142023-12-04

Conditions studied

Malaria, Vivax (2)  ·  Malaria (1)  ·  Malaria, Falciparum (1)

Sponsors

R. Kiplin Guy (2)

Countries

Peru (2)

Top investigators

Alejandro L Cuentas, MD, PhD (1)  ·  Alejandro L Cuentas,, MD, PhD (1)  ·  Rodney K Guy, PhD (1)